CLINICAL TRIALS PROFILE FOR BESIFLOXACIN HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for BESIFLOXACIN HYDROCHLORIDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00347932 ↗ | A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis. | Completed | Bausch & Lomb Incorporated | Phase 3 | 2006-06-01 | Evaluation of the clinical and microbial efficacy of 0.6% ISV-403, compared to vehicle in the treatment of bacterial conjunctivitis. |
NCT00348348 ↗ | A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis | Completed | Bausch & Lomb Incorporated | Phase 3 | 2006-06-01 | This is a study to investigate a novel drug candidate for the treatment of bacterial conjunctivitis. |
NCT00407589 ↗ | Systemic Pharmacokinetics of BOL-303224-A | Completed | Bausch & Lomb Incorporated | Phase 1 | 2006-10-01 | This is a multi-center, open-label, single dose/multiple dose, pharmacokinetic study in participants with bacterial conjunctivitis. The purpose of this study is to determine the extent of systemic exposure to BOL-303224-A following single and multiple topical administration of BOL-303224-A in participants with suspected bacterial conjunctivitis. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for BESIFLOXACIN HYDROCHLORIDE
Condition Name
Clinical Trial Locations for BESIFLOXACIN HYDROCHLORIDE
Trials by Country
Clinical Trial Progress for BESIFLOXACIN HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for BESIFLOXACIN HYDROCHLORIDE
Sponsor Name